breakout, page-24

"...800mg instead of 1200mg is GREAT news..."

It's already known that 800mg works well in clinical trials. It is now safe to assume that the 1200mg dosing is not as effective or safe.

In my opinion 'great news' would be that the new dosing works even better than the old. Then avx would be sitting on an even better therapy than at present.

All we have now is a status quo.... except of course that the fda won't be pestering Avexa to run loads of extra trials with the higher dose.

best wishes to holders